Scientist looking at screen with sample

Technologies and Analytics in Precision Medicine

Pharmacy and biomolecular sciences

Why study Technologies and Analytics in Precision Medicine at RCSI?

The health sector is facing into a new era as it looks to incorporate the areas of data science, omics, bioinformatics, computational biology, artificial intelligence and machine-learning to create a future of ‘connected healthcare’.

We are seeing disruption to existing models of healthcare delivery, coupled with increasing demand for healthcare access, an aging population and the associated cost challenges, all of which have led to an increased focus on preventative medicine and tailored therapies for individual patients. The fusion of digital technology with traditional science will shape the future of healthcare not only in Ireland, but on a global scale as our world adapts.

With this, there is a need for a skilled and educated workforce that is focused on emerging and future healthcare technologies and who can deliver through multi-disciplinary and collaborative approaches. RCSI's Technologies and Analytics in Precision Medicine programmes aim to equip this talent pool to address emerging skills gaps and enable future growth in healthcare and the (bio) pharmaceutical industry.

Check out a recent article in The Irish Times about this exciting master's here.

This project has been supported by the Higher Education Authority under the Human Capital Initiative, Pillar 3. Grant agreement: 17796884 'Enabling Future Pharma’.

We have collaborated with industry partners Congenica Ltd, Novartis Ireland, Aerogen, S3 Connected Health, Inflection Biosciences, Phion Therapeutics and Almac in the development of the grant application that has led to this programme.